NATTILE CLARKE: Open Payments
NPI 1811374515 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 20 payments from 13 companies in 2025. Trend: 2023 $223 · 2024 $389 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $78 |
| Janssen Pharmaceuticals, Inc | 2 | $60 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $46 |
| Amgen Inc. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: FANAPT, SPRAVATO, GEMTESA, Cologuard Collection Kit, OTEZLA, XIFAXAN, REXULTI, GIVLAARI.
Industry payments across MD — which companies pay providers there.
